Changchun hi tech fell more than 8% in intraday diving

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

INMO: No Wires, No Limits, Pure Reality

In the realm of technology today, Augmented Reality (AR) has consistently captured our attention as one of the revolutionary technologies with the potential to reshape our way of life. INMO, (Chinese: 影目科技), one of the frontrunners in the AR glasses domain, has recently unveiled a paradigm-shifting AR eyewear product INMO Go, earning widespread attention.

First ESG Report of China's Liquor Industry has been Released

The social responsibility of wine companies has become a key driver for China's liquor industry to show a new image.

The Globalization Journey of Tineco

Lu Xiongwen(陆雄文), Dean of the School of Management at Fudan University, once commented on Tineco: "Tineco is the newborn of the Ecovacs Group. Although he is only 5 years old, he is talented, eager to learn, and likable, and even irresistible." "In some fields, Tineco can be called a'little Huawei '."

Niu Technologies Reports Q3 2023 Earnings with Revenue of CNY 927 Million

On November 20, Niu Technologies (NASDAQ: NIU), a leading electric vehicle company, announced its financial results for the quarter ended September 30, 2023. According to the report, Niu Technologies achieved a third-quarter revenue of CNY 927 million in 2023, a 12% increase from the previous quarter's CNY 830 million. The company reported a net loss of CNY 79.4 million, compared to a net profit of CNY 2.9 million in the same period last year.